Table 3.
Assessment marks depending on antibody, platform and protocol: conc. AB: concentrated antibody, RTU AB: ready-to-use antibody, LDT: lab developed test, IVD: in vitro diagnostic test
| Percentage (number) | No. of optimal | No. of good | No. of borderline | No. of poor | ||
|---|---|---|---|---|---|---|
| Antibody | A7H6R | 30 (3) | 0 | 2 | 1 | 0 |
| EPR17341 conc. AB (Abcam) | 30 (3) | 0 | 1 | 1 | 1 | |
| EPR17341 RTU AB (Ventana) | 40 (4) | 3 | 1 | 0 | 0 | |
| Platform | Ventana | 80 (8) | 3 | 4 | 1 | 0 |
| Dako Omnis | 20 (2) | 0 | 0 | 1 | 1 | |
| Protocol | LDT with conc. AB | 60 (6) | 0 | 3 | 2 | 1 |
| LDT with RTU AB | 10 (1) | 0 | 1 | 0 | 0 | |
| IVD assay | 30 (3) | 3 | 0 | 0 | 0 |